Two Seas Capital LP Esperion Therapeutics, Inc. Transaction History
Two Seas Capital LP
- $5.37 Billion
- Q2 2025
A detailed history of Two Seas Capital LP transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Two Seas Capital LP holds 9,954,975 shares of ESPR stock, worth $17.8 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
9,954,975
Previous 6,930,871
43.63%
Holding current value
$17.8 Million
Previous $9.98 Million
2.25%
% of portfolio
0.18%
Previous 0.36%
Shares
9 transactions
Others Institutions Holding ESPR
# of Institutions
183Shares Held
106MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$21 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$18.5 Million0.05% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$12 Million4.26% of portfolio
-
Marshall Wace, LLP London, X05.31MShares$9.51 Million0.01% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $119M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...